Lexaria Bioscience Corp. (LEXX)
1.04
+0.17
(+20.08%)
USD |
NASDAQ |
Apr 02, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Market Cap : 30.78M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 106.70M |
| Aurinia Pharmaceuticals, Inc. | 2.092B |
| Edesa Biotech, Inc. | 56.70M |
| Xenon Pharmaceuticals, Inc. | 5.444B |
| ProMIS Neurosciences, Inc. | 26.10M |
Market Cap Related Metrics
| PS Ratio | 38.23 |
| PEG Ratio | -0.1041 |
| Price to Book Value | 5.268 |
| Price | 1.04 |
| Earnings Yield | -55.23% |
| PEGY Ratio | -0.1041 |